Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Phase II Bladder Cancer Clinical Study (Pivotal)

<< Previous

Bullboard Posts

Next >>

Post by floatinketuckyon Feb 13, 2021 11:18pm

331 Views

Post# 32563731

Phase II Bladder Cancer Clinical Study (Pivotal)

University Health Network (“UHN”) Toronto, Ontario

London Health Sciences Centre (“LHSC”) London, Ontario

Nova Scotia Health Authority (“NSHA”) Halifax, Nova Scotia

University of British Columbia (“UBC”) Vancouver, British Columbia

McGill University Health Centre (“MUHC”) Montreal, Quebec

Virginia Urology (“VU”) Richmond, Virginia

Urology Associates P.C. (“UA”) Nashville, Tennessee

MidLantic Urology (“MU”) Bala Cynwyd, Pennsylvania

Carolina Urolologic Research Centre (“CURC”) Myrtle Beach, SC

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec